Home » Topics » Pharmaceuticals » Commercial Operations

April 3, 2020
Drugmakers Deploy Medical Staff for COVID-19 Efforts
Pfizer, Eli Lilly and Merck are allowing their employees who are licensed medical professionals to volunteer in COVID-19 medical efforts.
April 2, 2020
Novartis Scraps $1 Billion Sandoz Sale to Aurobindo
Novartis and Aurobindo have terminated their $1 billion deal to sell the Sandoz U.S. generic oral solids and dermatology business to Aurobindo.
March 27, 2020
Mylan Waives U.S. Distribution Rights for Kaletra Generic
The company said that it suspended its exclusivity to enable a greater supply of the drug should additional trials or evaluations show it has potential in treating COVID-19.

March 26, 2020
Bristol-Myers Squibb Delays MS Drug Launch Due to COVID-19
March 26, 2020
Pfizer and Mylan Delay Merger Due to COVID-19
March 23, 2020
HHS Gives Liability Cover for Coronavirus Countermeasures
March 20, 2020
Biogen Alleges New York Firm Copied its Alzheimer’s Candidate
March 20, 2020
Drugmakers Ramp Up Chloroquine Production, Donations

March 18, 2020
Hahn Quizzed on Drug Supply Chain
March 13, 2020
HHS Gives Liability Cover for Coronavirus Countermeasures
March 12, 2020
Drug Prices Increased Three Times Faster Than Inflation in a Decade, Study Finds
March 10, 2020
Lawmakers Question Hahn on Drug Supply Chain
March 4, 2020
Drug Prices Increased Three Times Faster Than Inflation in a Decade, Study Finds

Products

Events